Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Original Research

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective

       
Total article views   HTML views PDF downloads Totals
12,752 Dovepress* 11,581+ 2,121 13,702
PubMed Central* 1,171 484 1,655
Totals 12,752 2,605 15,357
*Since 23 August 2012
+Since July 2016

View citations on PubMed and Google Scholar